Latest in Highlight

Advertising Area






Latest in


Ibnsina Pharma net revenues rise 51.1% y-o-y to EGP 2.9bn in Q1 2018

Ibnsina Pharma achieved net revenues of EGP 2.9bn, up 51.1% year-over-year in the first quarter of 2018, the company announced on Monday. The company’s earnings before interest, taxes, depreciation, and amortisation (EBITDA) recorded a 69.4% year-over-year increase to reach EGP 92.3m in Q1 2018. Meanwhile, the net profit registered at EGP 28m in Q1 2018, …

Daily News Egypt

Ibnsina Pharma signs contracts with Novo Nordisk to distribute products in Egypt

Companies signed two contracts authorising Ibnsina Pharma to distribute 20+ stock-keeping units of life-saving diabetes care, among other products Ibnsina Pharma, Egypt’s fastest-growing and second-largest pharmaceutical distributor, has signed two contracts with Novo Nordisk, leading manufacturer of insulin and haemophilia treatment, to distribute over 20 stock-keeping units of its diabetes care, haemophilia, and growth disorder …

Daily News Egypt

End of Section